Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model.
Andreata F, Bonizzi A, Sevieri M, Truffi M, Monieri M, Sitia L, Silva F, Sorrentino L, Allevi R, Zerbi P, Marchini B, Longhi E, Ottria R, Casati S, Vanna R, Morasso C, Bellini M, Prosperi D, Corsi F, Mazzucchelli S.
Andreata F, et al. Among authors: sitia l.
Sci Rep. 2020 Jul 10;10(1):11425. doi: 10.1038/s41598-020-68205-w.
Sci Rep. 2020.
PMID: 32651443
Free PMC article.